Yang Li

Yang Li has a diverse work experience spanning various roles and industries. Yang is currently the Co-Founder & Chairman of ReviR Therapeutics since May 2021. Prior to that, they served as the Chairman of the Board at Aegicare starting from January 2017. Yang also worked as an Adjunct Professor at TongJi Medical College of HUST from January 2018 onwards. In their earlier career, they were a Senior Bioinformatics Scientist at Invitae from January 2015 to November 2016. Yang started their professional journey as a PhD Research Assistant at the University of Illinois at Urbana-Champaign, where they worked from July 2010 to January 2015. Yang also served on the Undergraduate Admission Committee at Peking University in 2009 and was an Exchange student at the National University of Singapore from August 2008 to December 2008.

Yang Li completed a Bachelor's degree in Mechanics and Economics (CCER) at Peking University from 2006 to 2010. In 2008, they also participated in an exchange program at the National University of Singapore, where they studied engineering. Later, from 2010 to 2015, Yang Li pursued a Doctor of Philosophy (Ph.D.) in Bioinformatics at the University of Illinois Urbana-Champaign.